Female Health (Nasdaq: FHCO) is expected to report Q4 earnings around Nov. 30. Here's what Wall Street wants to see:

The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Female Health's revenues will increase 33.9% and EPS will wane -35.3%.

The average estimate for revenue is $9.5 million. On the bottom line, the average EPS estimate is $0.11.

Revenue details
Last quarter, Female Health reported revenue of $8.7 million. GAAP reported sales were much higher than the prior-year quarter's $3.5 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
Last quarter, EPS came in at $0.09. GAAP EPS of $0.09 for Q3 were much higher than the prior-year quarter's $0.01 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Recent performance
For the preceding quarter, gross margin was 61.2%, 960 basis points better than the prior-year quarter. Operating margin was 32.4%, 1,960 basis points better than the prior-year quarter. Net margin was 29.5%, 1,770 basis points better than the prior-year quarter.

Looking ahead

The full year's average estimate for revenue is $34.6 million. The average EPS estimate is $0.34.

Investor sentiment
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 285 members out of 294 rating the stock outperform, and nine members rating it underperform. Among 55 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 55 give Female Health a green thumbs-up, and give it a red thumbs-down.

Can your portfolio provide you with enough income to last through retirement? You'll need more than Female Health. Learn how to maximize your investment income and get "The 3 DOW Stocks Dividend Investors Need." Click here for instant access to this free report.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis -- even one of our own -- helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.